Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : neurodegenerative diseases
Arcera–Fosun Pharma MoU to Boost Global Life Sciences & Neuroscience Innovation
04/28/2026 | Companies
Abu Dhabi,
Alzheimer’s disease,
Arcera Life Sciences,
biologics,
biotechnology,
biotechnology incubation,
cardiometabolic diseases,
cell therapy,
China,
drug development,
emerging markets,
Fosun Pharma,
gene therapy,
global healthcare,
healthcare infrastructure,
innovation,
international collaboration,
joint ventures,
licensing,
life sciences,
market access,
memorandum of understanding,
Middle East healthcare,
MoU,
neurodegenerative diseases,
neuroscience,
oncology,
pharmaceutical industry,
R&D,
radiopharmaceuticals,
rare diseases,
research and development,
siRNA therapies,
small molecules,
strategic partnership,
UAE,
Vision 2030
Teva’s Global Innovation Strategy: Advancing Healthcare Through Collaboration and Research
06/18/2025 | Companies
academic partnerships,
academic research,
AI drug development,
AI in healthcare,
AION Labs,
BioInnovators Forum,
biologics,
biomarkers,
clinical trials,
disease burden,
drug discovery,
epidemiology,
healthcare access,
healthcare innovation,
IMI,
innovation,
Israeli biotech,
medical education,
neurodegenerative diseases,
Organospheres,
patient access,
pharmaceutical research,
pharmaceutical startups,
public health research,
public-private partnerships,
PubMed publications,
R&D,
scientific collaboration,
Teva Pharmaceuticals,
translational medicine,
unmet medical needs
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com